News Archive
Promising new biomaterial for T cell therapy, cancer patients
Jonathan King
An Illinois research team led by scientist Hua Wang (RBTE), a professor of materials science and engineering, has developed a biomaterial for T cell immunotherapy that can…
Illinois chosen to co-lead new CZ Biohub in Chicago
News Bureau
The University of Illinois Urbana-Champaign has been chosen to co-lead the Chan Zuckerberg Biohub Chicago—a new biomedical hub—with researchers from Illinois, the University of…
Kathy Millage
Ananya Sen
Kathy Millage is an Office Administrator at the IGB.
Walking into the Carl R. Woese Institute for Genomic Biology can be intimidating. If you’re a researcher, the main…
Protecting genomic privacy through phone apps
Ananya Sen
Police are increasingly using genomic databases in their investigations. Concerningly, they often do so without a warrant requirement. A new paper co-written by Illinois…
Bringing Single-Cell Chemical Measurement Expertise to Cancer Research
Jonathan King
Jonathan Sweedler (BSD/CABBI/MMG), Professor in Chemistry and the Neuroscience Program and a research member with the Cancer Center at Illinois’ JumpStart Program, was recently…
Nanotechnology-themed Forum Week has middle schoolers exploring big questions about the smallest particles
Shelby Lawson
Children are encouraged to follow their interests and think about what they want to be when they grow up. But the scope of the careers they imagine might be limited if they don…
Book tackles myths about science of menstruation
Diana Yates
A new book from University of Illinois Urbana-Champaign anthropology professor Kathryn Clancy (EIRH) takes an unflinching look at the many ways humans have struggled – and…
A cold-specialized icefish species underwent major genetic changes as it migrated to temperate waters, new study finds
Shelby Lawson
Many animals have evolved to tolerate extreme environments, including being able to survive crushing pressures of ocean trenches, unforgiving heat of deserts, and limited…
Erik Nelson: A milestone in my career
Christine des Garennes
Several days following the Federal Drug Administration’s approval of a new cancer drug, Erik Nelson (ACPP) was still processing the news.
“It hasn’t sunk in yet that…